For instance, studies have demonstrated that insulin signaling defects in skeletal muscle from T2D patients are characterized by impaired phosphorylation of insulin receptor substrate (IRS)-1, reduced phosphatidylinositol (PI) 3-kinase activity, and decreased glucose transport activity [10]. The gene discussed is INS; the disease is type 2 diabetes mellitus.